£100.00

Hardback

This item is printed to order. Items which are printed to order are normally despatched and charged within 5-10 days.

Published: 12 August 2004

420 Pages | numerous figures and tables, 4pp colour plates

ISBN: 9780195152746

Also Available As:

Ebook

This title is available as an ebook. To purchase, visit your preferred ebook provider.

Bookseller Code (AU)

Connect with OUP

https://global.oup.com/academic/covers/pop-up/9780195152746

Late-Life Depression

Edited by Steven P. Roose,M.D. and Harold A. Sackeim

Society is aging and illnesses that are prevalent and devastating in older individuals will consume an increasingly greater share of our health ...

£100.00

Hardback

This item is printed to order. Items which are printed to order are normally despatched and charged within 5-10 days.

Published: 12 August 2004

420 Pages | numerous figures and tables, 4pp colour plates

ISBN: 9780195152746

Also Available As:

Ebook

This title is available as an ebook. To purchase, visit your preferred ebook provider.

Bookseller Code (AU)

Late-Life Depression

Edited by Steven P. Roose,M.D. and Harold A. Sackeim

Description

We live in an ageing world. Illnesses that are prevalent and cause significant morbidity and mortality in older people will consume an increasing share of health care resources. One such illness is depression. This illness has a particularly devastating impact in the elderly because it is often undiagnosed or inadequately treated. Depression not only has a profound impact on quality of life but it is associated with an increased risk of mortality from suicide and vascular disease. In fact for every medical illness studied, e.g. heart disease, diabetes, cancer, individuals who are depressed have a worse prognosis. Research has illuminated the physiological and behavioural effects of depression that accounts for these poor outcomes. The deleterious relationship between depression and other illnesses has changed the concept of late-life depression from a "psychiatric disorder" that is diagnosed and treated by a psychiatrist to a common and serious disorder that is the responsibility of all physicians who care for patients over the age of 60.

This is the first volume devoted to the epidemiology, phenomenology, psychobiology, treatment and consequences of late-life depression. Although much has been written about depressive disorders, the focus has been primarily on the illness as experienced in younger adults. The effects of ageing on the brain, the physiological and behavioural consequences of recurrent depression, and the impact of other diseases common in the elderly, make late-life depression a distinct entity. There is a compelling need for a separate research program, specialized treatments, and a book dedicated to this disorder. This book will be invaluable to psychiatrists, gerontologists, clinical psychologists, social workers, students, trainees, and others who care for individuals over the age of 60.

Late-Life Depression

Edited by Steven P. Roose,M.D. and Harold A. Sackeim

Introduction
Part 1: Epidemiology and the burden of illness
1:The epidemiology of depressive disorders in late life, Dan G. Blazer
2:The social and financial burden of late-life depression to society and individuals, Barry D. Lebowitz & Jason T. Olin
Part 2: The phenomenology and differential diagnosis of late-life mood disorders
3:Unipolar depression, George S. Alexopoulos & William Apfeldorf
4:Bipolar disorders, Robert C. Young
5:Dysthymic disorder in the elderly, D.P. Devanand
6:Non-major clinically significant depression in the elderly, Anand Kumar, Helen Lavretsky & Virginia Elderkin-Thompson
7:Mixed cognitive and depressive syndromes, Helen Lavretsky & Gary W. Small
8:Suicide, Yeates Conwell
9:Bereavement and depression, Paula J. Clayton
Part 3: The psychobiology of late-life depression
10:Neuropsychological assessment of late-life depression, Wilfred G. van Gorp, James C. Root & Harold A. Sackeim
11:Structural and functional brain imaging in late-life depression, Harold A. Sackeim
12:Late-life depression and the vascular hypothesis, K. R. Ranga Krishnan
13:Hypothalmic-pituitary-adrenal axis activity in mood and cognition in the elderly: Implications for symptoms and outcomes, Jennifer Keller, Theresa M. Buckley & Alan F. Schatzberg
14:The neuroendocrinology of ageing, Stuart N. Seidman
Part 4: Treatment
15:Pharmacokinetics and pharmacodynamics in late life, Bruce G. Pollock
16:Antidepressant medication for the treatment of late-life depression, Steven P. Roose & Harold A. Sackeim
17:Antidepressant side effects, Carl Salzman
18:Mood stabilizers, Charles L. Bowden & Nancy U. Karren
19:Stimulants, J. Craig Nelson & Leon J. Epstein
20:Antipsychotics, Christian R. Dolder, Jonathan P. Lacro & Dilip V. Jeste
21:Electroconvulsive therapy in late-life depression, Harold A. Sackeim
22:Pharmacologic treatment of depression in Alzheimer's disease, John L. Beyer & P. Murali Doraiswamy
23:Psychotherapy in old-age depression: progress and challenges, Charles F. Reynolds III, Patricia A. Arean, Thomas R. Lynch & Ellen Frank
24:Treatment of depression in residential settings, Ira R. Katz & Joel Streim
Part 5: Depression co-morbid with other illnesses
25:Depression co-morbid with ischemic heart disease, Steven P. Roose & Alexander H. Glassman
26:Vascular disease and late-life depression: Stroke, Robert G. Robinson
27:Substance abuse co-morbidity, David W. Oslin
28:Basal ganglia disease and depression, Anjan Chatterjee & Karen Marder
29:Major depressive disorder in Alzheimer's disease, George S. Zubenko